Literature DB >> 15476051

Molecular epidemiology and antimicrobial susceptibility of Enterococci recovered from Brazilian intensive care units.

Ricardo Titze-de-Almeida1, Maurício Rollo Filho, Celeste A Nogueira, Isabela P Rodrigues, João Eudes Filho, Rejane S do Nascimento, Renato F Ferreira, Lídia M P Moraes, Hélène Boelens, Alex Van Belkum, Maria Sueli Soares Felipe.   

Abstract

We studied the antimicrobial resistance and the molecular epidemiology of 99 enterococcal surveillance isolates from two hospitals of Brasilia, Brazil. Conventional biochemical tests were used to identify the enterococcal species and the disk diffusion method was used to determine their resistance profiles. Enterococcus faecalis (76%) and E. faecium (9%) were the most prevalent species. No enterococci showed the vanA or vanB vancomycin resistance phenotypes or genotypes. Only the intrinsically resistant species E. gallinarum (n=2) and E. casseliflavus (n=3) harbored the vancomycin-resistance genes vanC1 and vanC2/3, respectively. We found E. faecalis isolates with high-level resistance to gentamicin (22%) and streptomycin (8%) and both E. faecalis and E. faecium isolates with resistance to more than two antimicrobials (84% and 67%, respectively). Nine E. faecalis isolates (12%) were resistant to ampicillin; the minimal inhibitory concentration (MIC) values were 16 microg/mL (n=6) and 32 microg/mL (n=3). Among these ampicillin-resistant E. faecalis, seven were also resistant to gentamicin, ciprofloxacin, rifampin, penicillin, chloramphenicol, tetracycline and erythromycin. Pulsed-field gel electrophoresis classified those isolates in three different genotypes, suggesting dissemination of genetically related ampicillin-resistant E. faecalis strains among different patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476051     DOI: 10.1590/s1413-86702004000300002

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  6 in total

1.  Virulence determinants in vancomycin-resistant Enterococcus faecium vanA isolated from different sources at University Hospital of Londrina, Paraná, Brazil.

Authors:  Flávia Imanishi Ruzon; Suelen Balero de Paula; Renata Lumi Kanoshiki; Jussevania Pereira-Santos; Gilselena Kerbauy; Renata Katsuko Takayama Kobayashi; Lucy Megumi Yamauchi; Márcia Regina Eches Perugini; Sueli Fumie Yamada-Ogatta
Journal:  J Microbiol       Date:  2011-01-09       Impact factor: 3.422

2.  Correlation between biofilm formation and gelE, esp, and agg genes in Enterococcus spp. clinical isolates.

Authors:  Renata O Soares; Ana Cláudia Fedi; Keli C Reiter; Juliana Caierão; Pedro A d'Azevedo
Journal:  Virulence       Date:  2014-04-29       Impact factor: 5.882

3.  Absence of VanA- and VanB-containing enterococci in poultry raised on nonintensive production farms in Brazil.

Authors:  Diego Batista Xavier; Francisco Ernesto Moreno Bernal; Ricardo Titze-de-Almeida
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

4.  Prevalence of high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium in an Iranian hospital.

Authors:  M Emaneini; B Khoramian; F Jabalameli; R Beigverdi; K Asadollahi; M Taherikalani; A R Lari
Journal:  J Prev Med Hyg       Date:  2016-12

5.  Occurrence of multidrug-resistant and toxic-metal tolerant enterococci in fresh feces from urban pigeons in Brazil.

Authors:  Vânia Lúcia da Silva; Natália Cândido Caçador; Carolina dos Santos Fernandes da Silva; Cláudia Oliveira Fontes; Gizele Duarte Garcia; Jacques Robert Nicoli; Cláudio Galuppo Diniz
Journal:  Microbes Environ       Date:  2012       Impact factor: 2.912

6.  Enterococcus faecium and Enterococcus faecalis in blood of newborns with suspected nosocomial infection.

Authors:  Isabela Furtado; Paula Cristhina Niz Xavier; Luciana Venhofen Martinelli Tavares; Fabiana Alves; Sarah Fonseca Martins; Almir de Sousa Martins; Durval Batista Palhares
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.